Research · 2026-01-01
7-OH Contamination and Degradation in Commercial Kratom Products Raises Safety Concerns
Source: PubMed/Pharmaceuticals Journal
Why it matters
Consumers purchasing kratom products may be receiving mislabeled 7-OH concentrations, some exceeding 33.6mg per serving. These findings highlight critical gaps in product safety and labeling accuracy that directly affect consumer health.
The big picture
The kratom marketplace has evolved dramatically, with synthetic 7-OH products now dominating the market. Unlike traditional leaf kratom (typically 1-2% 7-OH), these concentrated products are highly potent and carry significant addiction risks. This analysis reveals that manufacturers may not accurately label 7-OH content, and 7-OH degrades into potentially toxic byproducts under stomach conditions.
Key findings
- Analysis of >98% of 7-OH-labeled products revealed semisynthetic origins with doses ranging from 0.001 to 33.6 mg per serving; substantial inconsistencies between label claims and actual 7-OH content detected; 7-OH degrades into 3-dehydromitragynine under simulated gastric conditions; several over-oxidized byproducts found, indicating synthetic manufacturing processes
What they say
The research team concluded that 'these findings underscore significant safety concerns over oral 7-OH products and necessitate validated analytical monitoring to guide regulatory oversight and consumer protection.'
Bottom line
**Synthetic 7-OH kratom products are largely mislabeled and degrade into potentially harmful compounds, requiring immediate regulatory intervention and consumer warnings.**